Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas Mai

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Journal of School Nursing : the Official Publication of the National Association of School Nurses|February 7, 2009
Assessment of ankle injuriesNicholas Mai, Leslie Cooper
Clinical Breast Cancer|June 19, 2023
Molecularly Targeted Therapies for Triple Negative Breast Cancer: History, Advances, and Future DirectionsNicholas Mai, Nour Abuhadra, Komal Jhaveri
Cancer Discovery|December 2, 2025
Precision Oncology: 2025 in ReviewNicholas Mai, Nicole Fernandez, Alexander Drilon, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 23, 2017
PD-L1 Immunohistochemistry Highlights Bone Marrow Involvement by Classic Hodgkin Lymphoma in Staging Biopsies: Implications for Diagnosis and Tumor Microenvironment AlterationsWei Xing, Nicholas Mai, Karen Dresser, et al.
NPJ Precision Oncology|July 28, 2024
Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancerNicholas Mai, Jie-Fu Chen, Satshil Rana, et al.
Surgery|December 21, 2005
Insulin prevents oxidant-induced endothelial cell barrier dysfunction via nitric oxide-dependent pathwaySiddhartha Rath, Theodore Kalogeris, Nicholas Mai, et al.
NPJ Breast Cancer|June 4, 2024
Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancerNicholas Mai, Sara Myers, Sherry Shen, et al.
Lung Cancer (Amsterdam, Netherlands)|May 21, 2020
Propensity score adjusted analysis of patients with isolated locoregional recurrence versus de novo locally advanced NSCLC treated with definitive therapyCole Friedes, Nicholas Mai, Wei Fu, et al.
Clinical Lung Cancer|July 7, 2020
Consolidative Radiotherapy in Oligometastatic Lung Cancer: Patient Selection With a Prediction NomogramCole Friedes, Nicholas Mai, Sarah Hazell, et al.
Cancer|July 31, 2020
Isolated progression of metastatic lung cancer: Clinical outcomes associated with definitive radiotherapyCole Friedes, Nicholas Mai, Wei Fu, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Journal of School Nursing : the Official Publication of the National Association of School Nurses|February 7, 2009
Assessment of ankle injuriesNicholas Mai, Leslie Cooper
Clinical Breast Cancer|June 19, 2023
Molecularly Targeted Therapies for Triple Negative Breast Cancer: History, Advances, and Future DirectionsNicholas Mai, Nour Abuhadra, Komal Jhaveri
Cancer Discovery|December 2, 2025
Precision Oncology: 2025 in ReviewNicholas Mai, Nicole Fernandez, Alexander Drilon, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|December 23, 2017
PD-L1 Immunohistochemistry Highlights Bone Marrow Involvement by Classic Hodgkin Lymphoma in Staging Biopsies: Implications for Diagnosis and Tumor Microenvironment AlterationsWei Xing, Nicholas Mai, Karen Dresser, et al.
NPJ Precision Oncology|July 28, 2024
Pathologic complete response to KEYNOTE522 and HER2-directed therapy for synchronous TNBC and HER2+ breast cancerNicholas Mai, Jie-Fu Chen, Satshil Rana, et al.
Surgery|December 21, 2005
Insulin prevents oxidant-induced endothelial cell barrier dysfunction via nitric oxide-dependent pathwaySiddhartha Rath, Theodore Kalogeris, Nicholas Mai, et al.
NPJ Breast Cancer|June 4, 2024
Dose dense doxorubicin plus cyclophosphamide in a modified KEYNOTE522 regimen for triple negative breast cancerNicholas Mai, Sara Myers, Sherry Shen, et al.
Lung Cancer (Amsterdam, Netherlands)|May 21, 2020
Propensity score adjusted analysis of patients with isolated locoregional recurrence versus de novo locally advanced NSCLC treated with definitive therapyCole Friedes, Nicholas Mai, Wei Fu, et al.
Clinical Lung Cancer|July 7, 2020
Consolidative Radiotherapy in Oligometastatic Lung Cancer: Patient Selection With a Prediction NomogramCole Friedes, Nicholas Mai, Sarah Hazell, et al.
Cancer|July 31, 2020
Isolated progression of metastatic lung cancer: Clinical outcomes associated with definitive radiotherapyCole Friedes, Nicholas Mai, Wei Fu, et al.
Pageof 2